|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.70 SEK | +5.18% |
|
+9.06% | -31.23% |
| 06-09 | Orexo AB Announces Appointment of Raheleh Nassaji as Senior Vice President Business Development | CI |
| 06-09 | Orexo appoints new Head of Business Development | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OREXO AB | Specialty & Advanced Pharmaceuticals | +5.18% | +9.06% | -31.23% | +6.15% | -48.46% | 76.92M |  |  | |
- Stock Market
- Stocks
- ORX Stock
- Charts Orexo AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
